Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. doi:10.3322/caac.v63.123335087
   PubMed Web of Science ®Google Scholar
• Salim H, Zong D, Hååg P, et al. DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines. BMC Cancer. 2015;15:628–643. doi:10.1186/s12885-015-1635-926353782
   PubMed Web of Science ®Google Scholar
• Gao Y, Liu Z, Zhang X, et al. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells. Cancer Lett. 2013;336(1):231–239. doi:10.1016/j.canlet.2013.05.00523673211
   PubMed Web of Science ®Google Scholar
• Tang L, Wang Y, Wang H, et al. Long noncoding-RNA component of mitochondrial RNA processing endoribonuclease is involved in the progression of cholangiocarcinoma by regulating microRNA-217. Cancer Sci. 2019;110(7):2166–2179. doi:10.1111/cas.2019.110.issue-731111617
   PubMed Web of Science ®Google Scholar
• Liu D, Li Y, Luo G, et al. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2. Cancer Lett. 2017;388:281–291. doi:10.1016/j.canlet.2016.12.00527998761
   PubMed Web of Science ®Google Scholar
• Zhang W, Lei P, Dong X, et al. The new concepts on overcoming drug resistance in lung cancer. Drug Des Devel Ther. 2014;8:735–744. doi:10.2147/DDDT.S60672
   PubMed Web of Science ®Google Scholar
• Khaitan D, Dinger ME, Mazar J, et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 2011;71(11):3852–3862. doi:10.1158/0008-5472.CAN-10-446021558391
   PubMed Web of Science ®Google Scholar
• Shi Y, Li J, Liu Y, et al. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression. Mol Cancer. 2015;14:51. doi:10.1186/s12943-015-0318-025742952
   PubMed Web of Science ®Google Scholar
• Xie HW, Wu QQ, Zhu B, et al. Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis. Tumor Biol. 2014;35:7743–7754. doi:10.1007/s13277-014-2013-y
   PubMedGoogle Scholar
• Sun M, Liu X-H, Lu K-H, et al. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial–mesenchymal transition. Cell Death Dis. 2014;5:e1298. doi:10.1038/cddis.2014.25624967960
   PubMed Web of Science ®Google Scholar
• Xiong G, Feng M, Yang G, et al. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer. Cancer Lett. 2017;397:94–102. doi:10.1016/j.canlet.2017.02.02028254409
   PubMed Web of Science ®Google Scholar
• Wei L, Wang X, Lv L, et al. The emerging role of noncoding RNAs in colorectal cancer chemoresistance. [published online ahead of print July 29, 2019]. Cell Oncol (Dordr). 2019;42(6):757–768. doi:10.1007/s13402-019-00466-831359293
   PubMed Web of Science ®Google Scholar
• Liu Z, Sun M, Lu K, et al. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregulation of p21(WAF1/CIP1) expression. PLoS One. 2013;8(10):e77293. doi:10.1371/journal.pone.007729324155936
   PubMed Web of Science ®Google Scholar
• Liu J, Wan L, Lu K, et al. The noncoding RNA MEG3 contributes to cisplatin resistance of human lung adenocarcinoma. PLoS One. 2010;10(5):e0114586. doi:10.1371/journal.pone.0114586
   Google Scholar
• Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38–55. doi:10.1186/1476-4598-10-3821489289
   PubMed Web of Science ®Google Scholar
• Zhang Q, Huang F, Yao Y, et al. Interaction of transforming growth factor-β-Smads/microRNA-362-3p/CD82 mediated by M2 macrophages promotes the process of epithelial-mesenchymal transition in hepatocellular carcinoma cells. Cancer Sci. 2019;110(8):2507–2519. doi:10.1111/cas.1410131215741
   PubMed Web of Science ®Google Scholar
• Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69–84. doi:10.1038/s41580-018-0080-430459476
   PubMed Web of Science ®Google Scholar
• Jiang JG, Ning YG, Chen C, et al. Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res. 2007;67(14):6665–6674. doi:10.1158/0008-5472.CAN-06-364317638876
   PubMed Web of Science ®Google Scholar
• Shi ZQ, Lu W, Feng GS. The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun-terminal mitogen-activated protein kinases. J Biol Chem. 1998;273(9):4904–4908. doi:10.1074/jbc.273.9.49049478933
   PubMed Web of Science ®Google Scholar
• Zannettino AC, Roubelakis M, Welldon KJ, et al. Novel mesenchymal and haematopoietic cell isoforms of the SHP-2 docking receptor, PZR: identification, molecular cloning and effects on cell migration. Biochem J. 2003;370(Pt2):537–549. doi:10.1042/bj2002093512410637
   PubMedGoogle Scholar
• Eminaga S, Bennett AM. Noonan syndrome-associated SHP-2/Ptpn11 mutants enhance SIRPalpha and PZR tyrosyl phosphorylation and promote adhesion-mediated ERK activation. J Biol Chem. 2008;283(22):15328–15338. doi:10.1074/jbc.M80138220018378677
   PubMed Web of Science ®Google Scholar
• Jia D, Jing Y, Zhang Z, et al. Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma. Cell Res. 2014;24(2):204–217. doi:10.1038/cr.2013.15824296779
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629–641. doi:10.1016/j.cell.2009.02.00619239885
   PubMed Web of Science ®Google Scholar
• Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329:689–693. doi:10.1126/science.119200220616235
   PubMed Web of Science ®Google Scholar
• Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013;20:300–307. doi:10.1038/nsmb.248023463315
   PubMed Web of Science ®Google Scholar
• Natoli G, Andrau J-C. Noncoding transcription at enhancers: general principles and functional models. Annu Rev Genet. 2012;46:1–19. doi:10.1146/annurev-genet-110711-15545922905871
   PubMed Web of Science ®Google Scholar